Our Team
Ashley Abel, PhD
Co-Founder & CEO
Kathy Potts, PhD
Co-Founder & COO
Berna Sozen, PhD
Academic Co-Founder & SAB Chair
Yale Professor of Genetics and Obstetrics/Gynecology
Thomas de Vlaam
Lead Investor & Chairman
Laura Bahlmann, PhD
Lead Scientist
Emily Scott-Solomon, PhD
Lead Scientist
Hugh Taylor, MD
Scientific Advisor, Metri Bio
Chief & Chair of Obstetrics and Gynecology at Yale School of Medicine; Former President, ASRM and SRI
Denny Sakkas, PhD
Scientific Advisor, Metri Bio
Chief Scientific Officer at Boston IVF
Frederick Naftolin, MD, PhD
Scientific Advisor, Metri Bio
Former Chair of Obstetrics & Gynecology at Yale University and New York University, and Former President of the Society for Reproductive Investigation (SRI)
Timo Kohler, PhD
Scientific Advisor, Metri Bio
Principal Investigator, University of Hamburg
Matteo Boretto, PhD
Scientific Advisor, Metri Bio
Senior Scientist, Princess Maxima Center for Pediatric Oncology
Maria Lalioti, PhD
Scientific Advisor, Metri Bio
Human geneticist. Former VP at Beam Therapeutics and Director at Biogen
Doug Williams, PhD
Scientific Advisor, Metri Bio
Former Head of R&D, Biogen
Adriana N. Vélez-Avilés
Consultant, Metri Bio
MD-PhD student Yale University and University of Puerto Rico
Irem Beyza Uralcan
Consultant, Metri Bio
Postgraduate Research Assistant, Yale University
Our mission